Saracatinib is a small molecule which can act as a Src family kinase inhibitor. It is provided as a powder.
This product acts on the following target types: Kinase.
This product acts on the following biochemical pathways: Cell migration, Proliferation, Cell adhesion, PI3k, ERK.
This product may be interest in the following research areas and diseases: Neuroscience, Neurodegeneration, Infectious disease, Cancer.
Please note that our chemical products are for research use only in a laboratory and are not for medical or veterinary use.